−0.786SEK
−64.89 MSEK
120.86 M
About KANCERA AB
Sector
CEO
Peter Selin
Headquarters
Solna
Website
Employees (FY)
3
Founded
2010
ISIN
SE0015658570
FIGI
BBG001Y25L94
Kancera AB engages in the research, development and sale of drug candidate to pharmaceutical companies. Its portfolio includes Fractalkine, ROR inhibitors, HDAC6 and PFKFB3 projects. The company was founded by Hakan Mellstedt on April 28, 2010 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KAN is 1.496 SEK — it has decreased by 3.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange KANCERA AB stocks are traded under the ticker KAN.
KANCERA AB is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
KAN stock is 6.78% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is KANCERA AB there?
Yes, you can track KANCERA AB financials in yearly and quarterly reports right on TradingView.
KAN stock has fallen by 1.84% compared to the previous week, the month change is a 19.83% fall, over the last year KANCERA AB has showed a 53.31% decrease.
KAN net income for the last quarter is −18.47 M SEK, while the quarter before that showed −10.73 M SEK of net income which accounts for −72.07% change. Track more KANCERA AB financial stats to get the full picture.
Today KANCERA AB has the market capitalization of 187.35 M, it has decreased by 1.58% over the last week.
No, KAN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANCERA AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 3.00 employees. See our rating of the largest employees — is KANCERA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KANCERA AB technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KANCERA AB stock shows the sell signal. See more of KANCERA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.